CONMED Corporation
US ˙ NYSE ˙ US2074101013

Introduction

This page provides a comprehensive analysis of the known insider trading history of Charles Farkas. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Charles Farkas has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CNMD / CONMED Corporation Director 16,859
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Charles Farkas. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CNMD / CONMED Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CNMD / CONMED Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2017-07-05 CNMD Farkas Charles 157 50.7800 157 50.7800 7,972 352 76.4300 4,028 50.52

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CNMD / CONMED Corporation Insider Trades
Insider Sales CNMD / CONMED Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CNMD / CONMED Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-05-05 CNMD Farkas Charles 4,000 56.9420 4,000 56.9420 227,768 74 47.6400 -37,208 -16.34

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CNMD / CONMED Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Charles Farkas as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-06-04 2025-06-03 4 CNMD CONMED Corp
Common Stock
M - Exercise 479 16,859 2.92
2025-05-30 2025-05-29 4 CNMD CONMED Corp
Common Stock
F - Taxes -966 16,380 -5.57 57.69 -55,729 944,962
2025-05-30 2025-05-29 4 CNMD CONMED Corp
Common Stock
M - Exercise 1,000 17,346 6.12 55.70 55,700 966,172
2025-05-06 2025-05-05 4 CNMD CONMED Corp
Common Stock
S - Sale -4,000 16,346 -19.66 56.94 -227,768 930,774
2024-09-09 2024-09-05 4 CNMD CONMED Corp
Common Stock
F - Taxes -534 20,346 -2.56 74.31 -39,682 1,511,911
2024-09-09 2024-09-05 4 CNMD CONMED Corp
Common Stock
M - Exercise 1,000 20,880 5.03 39.64 39,640 827,683
2024-06-04 2024-05-31 4 CNMD CONMED Corp
Common Stock
M - Exercise 302 19,880 1.54
2023-06-02 2023-06-01 4 CNMD CONMED Corp
Common Stock
M - Exercise 335 19,578 1.74
2022-06-02 2022-06-01 4 CNMD CONMED Corp
Common Stock
M - Exercise 812 19,243 4.41
2021-06-03 2021-06-01 4 CNMD CONMED Corp
Options To Purchase Common Stock
A - Award 865 865
2021-06-03 2021-06-01 4 CNMD CONMED Corp
Rsus (restricted Stock Units)
A - Award 812 812
2021-06-03 2021-06-01 4 CNMD CONMED Corp
Rsus (restricted Stock Units)
M - Exercise -1,521 0 -100.00
2021-06-03 2021-06-01 4 CNMD CONMED Corp
Common Stock
M - Exercise 1,521 18,431 8.99
2020-06-03 2020-06-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 1,843 1,843
2020-06-03 2020-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 1,521 1,521
2020-06-03 2020-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -1,407 0 -100.00
2020-06-03 2020-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 1,407 16,910 9.08
2019-06-04 2019-06-03 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 2,165 2,165
2019-06-04 2019-06-03 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 1,407 1,407
2019-06-04 2019-05-31 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -1,629 0 -100.00
2019-06-04 2019-05-31 4 CNMD CONMED CORP
Common Stock
M - Exercise 1,629 15,503 11.74
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 2,549 2,549
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 1,629 1,629
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -2,167 0 -100.00
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 2,167 13,874 18.51
2018-01-04 2018-01-03 4 CNMD CONMED CORP
Common Stock
P - Purchase X 158 11,707 1.37 50.61 7,996 592,491
2017-10-03 2017-10-03 4 CNMD CONMED CORP
Common Stock
P - Purchase X 148 11,549 1.30 53.96 7,986 623,184
2017-07-06 2017-07-05 4 CNMD CONMED CORP
Common Stock
P - Purchase 157 11,401 1.40 50.78 7,972 578,943
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 3,669 3,669 51.90 190,421 190,421
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 2,167 2,167
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -2,739 0 -100.00
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 2,739 11,244 32.20
2017-04-04 2017-04-03 4 CNMD CONMED CORP
Common Stock
P - Purchase X 180 8,505 2.16 44.41 7,994 377,707
2017-01-04 2017-01-03 4 CNMD CONMED CORP
Common Stock
P - Purchase X 305 8,325 3.80 44.65 13,618 371,711
2016-10-04 2016-10-03 4 CNMD CONMED CORP
Common Stock
P - Purchase X 336 8,020 4.37 40.04 13,453 321,121
2016-07-05 2016-07-01 4 CNMD CONMED CORP
Common Stock
P - Purchase X 282 7,684 3.81 47.87 13,499 367,833
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 2,739 2,739
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 5,396 5,396
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -3,000 0 -100.00
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 3,000 7,402 68.15
2016-04-04 2016-04-01 4 CNMD CONMED CORP
Common Stock
P - Purchase X 3 4,402 0.07 42.06 126 185,148
2016-04-04 2016-04-01 4 CNMD CONMED CORP
Common Stock
P - Purchase X 335 4,399 8.24 42.04 14,083 184,934
2016-01-04 2016-01-04 4 CNMD CONMED CORP
Common Stock
P - Purchase X 332 4,064 8.90 42.18 14,005 171,431
2015-10-02 2015-10-01 4 CNMD CONMED CORP
Common Stock
P - Purchase X 290 3,732 8.43 47.74 13,845 178,166
2015-10-02 2015-10-01 4 CNMD CONMED CORP
Common Stock
P - Purchase X 2 3,442 0.06 47.24 94 162,600
2015-07-02 2015-07-02 4 CNMD CONMED CORP
Common Stock
P - Purchase X 205 3,440 6.34 58.66 12,024 201,774
2015-07-02 2015-06-01 4/A CNMD CONMED CORP
Sars (Stock Appreciation Rights)
A - Award 1,000 1,000
2015-07-02 2015-06-01 4/A CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 3,000 3,000
2015-06-03 2015-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -3,000 0 -100.00
2015-06-03 2015-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 3,000 3,235 1,276.60
2015-04-02 2015-04-01 4 CNMD CONMED CORP
Common Stock
P - Purchase X 99 235 72.79 50.78 5,027 11,933
2015-04-02 2015-04-01 4 CNMD CONMED CORP
Common Stock
P - Purchase X 100 136 277.78 50.73 5,073 6,899
2015-04-02 2015-04-01 4 CNMD CONMED CORP
Common Stock
P - Purchase X 36 36 50.68 1,824 1,824
2014-09-15 2014-09-11 4 CNMD CONMED CORP
Sars (Stock Appreciation Rights)
A - Award 1,000 1,000
2014-09-15 2014-09-11 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 3,000 3,000
2014-08-04 3 CNMD CONMED CORP
Common Stock
0
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)